L
Lecanemab [Leqembi]
Availability of ACE Drug Guidance
Yes
Biologics Drug Information Overview
No
Post-marketing information
Patient Alert Card
Physician Educational Material
Subsidy Information and Financing Scheme
No
Active ingredient: Lecanemab
General information
Subsidy Information and Financing Scheme
Not Applicable
Drug Guidance for Subsidy
[NR] Donanemab and lecanemab are not recommended for inclusion on the MOH List of Subsidised Drugs for treating mild cognitive impairment and mild dementia due to Alzheimer’s disease.
[NR] This is because the current available evidence shows that the treatment effects for donanemab and for lecanemab were small with uncertain clinical meaningfulness, and the short trial durations limited the understanding of the treatments’ impact over the full course of the disease.
[NR] Given the uncertainty in clinical benefit and significant additional healthcare resources required to assess treatment eligibility and risks, as well as for regular magnetic resonance imaging (MRI) monitoring, funding these drugs would not represent a cost-effective use of healthcare resources and could place undue strain on the healthcare system.
Post Marketing Information
Registered Product(s) Information
Clinical and product info
Clinical info | Product Info |
|---|---|
Information under the Indication, Dosage and Contraindication sections are extracted from the relevant Package Insert/Patient Information Leaflet of the product available on HSA Infosearch. For more information, please refer to the product's Package Insert/ Patient Information Leaflet available on HSA Infosearch. The information provided is for informational purposes only, and is not exhaustive. The information provided is not a substitute for professional medical advice. Please consult a qualified healthcare provider for any medical advice. | Information available here are product details as registered with the HSA. As this website is updated monthly, please refer to HSA Infosearch for the most updated product information. |
Intravenous
* Clinical information is available for this product.